Dr Dheeraj Kalladka

Affiliate Clinical Fellow (School of Psychology & Neuroscience)

email: Dheeraj.Kalladka@glasgow.ac.uk

Ground Floor, Office Block, Queen Elizabeth University Hospital, Glasgow G51 4TF, G51 4TF

Import to contacts

Publications

List by: Type | Date

Jump to: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2011

Number of items: 15.

2021

Huang, X., Malek, N., Simpson, J., Kalladka, D., Dunn, F. G. and Leach, J. P. (2021) Winning hearts and minds: ECG reporting in the first seizure clinic. BMC Cardiovascular Disorders, 21, 364. (doi: 10.1186/s12872-021-02174-4) (PMID:34332536) (PMCID:PMC8325235)

2020

Bivard, A. et al. (2020) Comparing mismatch strategies for patients being considered for ischemic stroke tenecteplase trials. International Journal of Stroke, 15(5), pp. 507-515. (doi: 10.1177/1747493019884529) (PMID:31684841)

2019

Kalladka, D., Sinden, J., McLean, J., Moreton, F. C., Huang, X. and Muir, K. W. (2019) Increased deep grey matter functional connectivity of poststroke hNSC implanted ipsilesional putamen. Journal of Neurology, Neurosurgery and Psychiatry, 90(8), pp. 959-960. (doi: 10.1136/jnnp-2018-319022) (PMID:30530567)

Al-Shahi Salman, R. et al. (2019) Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial. Lancet Neurology, 18(7), pp. 643-652. (doi: 10.1016/S1474-4422(19)30184-X) (PMID:31129065)

Al-Shahi Salman, R. et al. (2019) Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Lancet, 393(10191), pp. 2613-2623. (doi: 10.1016/S0140-6736(19)30840-2) (PMID:31128924) (PMCID:PMC6617509)

2018

Al-Shahi Salman, R. et al. (2018) The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial. Trials, 19, 162. (doi: 10.1186/s13063-018-2542-6) (PMID:29506580) (PMCID:PMC5838871)

2017

Huang, X., Kalladka, D., Cheripelli, B. K., Moreton, F. C. and Muir, K. W. (2017) The impact of CT perfusion threshold on predicted viable and nonviable tissue volumes in acute ischaemic stroke. Journal of Neuroimaging, 27(6), pp. 602-606. (doi: 10.1111/jon.12442) (PMID:28414895)

Bivard, A. et al. (2017) Tenecteplase in ischemic stroke offers improved recanalization: analysis of 2 trials. Neurology, 89(1), pp. 62-67. (doi: 10.1212/WNL.0000000000004062) (PMID:28576782)

Bivard, A. et al. (2017) Impact of computed tomography perfusion imaging on the response to tenecteplase in ischemic stroke: analysis of two randomized controlled trials. Circulation, 135(5), pp. 440-448. (doi: 10.1161/CIRCULATIONAHA.116.022582) (PMID:27965285)

2016

El Tawil, S., Cheripelli, B., Huang, X., Moreton, F., Kalladka, D., MacDougal, N. J.J., McVerry, F. and Muir, K. W. (2016) How many stroke patients might be eligible for mechanical thrombectomy? European Stroke Journal, 1(4), pp. 264-271. (doi: 10.1177/2396987316667176)

Kalladka, D. et al. (2016) Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. Lancet, 388(10046), pp. 787-796. (doi: 10.1016/S0140-6736(16)30513-X) (PMID:27497862)

Cullen, B. , Moreton, F. C., Stringer, M. S., Krishnadas, R. , Kalladka, D., López-González, M. R., Santosh, C., Schwarzbauer, C. and Muir, K. W. (2016) Resting state connectivity and cognitive performance in adults with cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Journal of Cerebral Blood Flow and Metabolism, 36(5), pp. 981-991. (doi: 10.1177/0271678X16636395) (PMID:26929239)

2015

Huang, X., Moreton, F., Kalladka, D., Cheripelli, B. K., Macisaac, R., Tait, R. C. and Muir, K. (2015) Coagulation and fibrinolytic activity of tenecteplase and alteplase in acute ischemic stroke. Stroke, 46(12), pp. 3543-3546. (doi: 10.1161/strokeaha.115.011290) (PMID:26514192)

Huang, X., Cheripelli, B. K., Lloyd, S. M. , Kalladka, D., Moreton, F. C., Siddiqui, A., Ford, I. and Muir, K. W. (2015) Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST): phase 2 randomised clinical trial. Lancet Neurology, 14(4), pp. 368-376. (doi: 10.1016/S1474-4422(15)70017-7) (PMID:25726502)

2011

Kalladka, D. and Muir, K.W. (2011) Stem cell therapy in stroke: designing clinical trials. Neurochemistry International, 59(3), pp. 367-370. (doi: 10.1016/j.neuint.2011.03.016)

This list was generated on Thu Sep 28 15:40:44 2023 BST.

Jump to: Articles